tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market

Coherus Biosciences (CHRS) Cash flow

Compare
1,637 Followers

Coherus Biosciences Cash Flow

CHRS's free cash flow for Q3 2025 was $-46.34M. For the 2025 fiscal year, CHRS's free cash flow was decreased by $154.73M and operating cash flow was $-46.34M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -20.44M$ -174.88M$ -241.12M$ -37.43M$ 154.15M
Investing Cash Flow
$ 230.32M$ 144.64M$ -166.85M$ -138.41M$ -14.40M
Financing Cash Flow
$ -186.97M$ 69.60M$ 54.33M$ 51.88M$ 223.95M
End Cash Position
$ 126.25M$ 102.89M$ 63.99M$ 417.63M$ 541.60M
Free Cash Flow
$ -20.44M$ -175.17M$ -243.16M$ -38.72M$ 146.91M
Currency in USD

Coherus Biosciences Cash Flow